Full Text View
Tabular View
No Study Results Posted
Related Studies
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
This study has been completed.
Study NCT00625404   Information provided by FHI 360

First Received on February 19, 2008.   Last Updated on March 27, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Truvada®
Placebo
Additional drug interventions recognized in this trial
Carboxymethylcellulose Sodium
Emtricitabine
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Gastrointestinal Agents
Laxatives
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
FHI 360


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services